Aktie 300813 ZHEJIANG TAILIN BIOENGINEERING CO.,LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Zhejiang Tailin BioEngineering Co.,Ltd

Aktien

300813

CNE100003S89

300813

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 14.05.2024 		% 5 Tage % 1. Jan.
23,94 CNY -12,95 % Intraday Chart für Zhejiang Tailin BioEngineering Co.,Ltd +28,43 % -2,37 %
24.04. Zhejiang Tailin BioEngineering Co.,Ltd schlägt letzte Bardividende für 2023 vor CI
23.04. Zhejiang Tailin BioEngineering Co.,Ltd meldet Ergebnis für das erste Quartal zum 31. März 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for 2023
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Zhejiang Tailin Medical Engineering Co., Ltd. announced that it expects to receive CNY 170 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Zhejiang Tailin Bioengineering Co.,Ltd Approves Cash Dividend for the Year 2022, Payable on 11 May 2023
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Zhejiang Tailin Bioengineering Co.,Ltd. Proposes Final Cash Dividend for 2022
Certain A Shares of Zhejiang Tailin BioEngineering Co.,Ltd are subject to a Lock-Up Agreement Ending on 15-JAN-2023.
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
Zhejiang Tailin Medical Engineering Co., Ltd. announced that it has received CNY 40 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd
Zhejiang Tailin Bioengineering Co.,Ltd Approves the Final Cash Dividend for the Year 2021, Payable on May 18, 2022
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for the Year of 2021
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
Zhejiang Tailin Life Science Co., Ltd. announced that it expects to receive CNY 40 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd
Zhejiang Tailin Bioengineering Sells $33 Million RMB Convertible Bonds
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
Zhejiang Tailin Bioengineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 300813 Aktie
  4. Nachrichten Zhejiang Tailin BioEngineering Co.,Ltd
  5. Andere Sprachen